Corrigendum to “Effect of polycyclic aromatic hydrocarbon exposure on amnestic mild cognitive impairment and Alzheimer's disease: A matched case-control study” [Heliyon Volume 10, Issue 15, August 2024, Article e35614] (Heliyon (2024) 10(15), (S2405844024116453), (10.1016/j.heliyon.2024.e35614))

In this article, the Institutional Review Board approval number for the Samsung Medical Center was initially reported incorrectly. The original version stated: Ethics approval and consent to participate This study was conducted in accordance with the principles of the Declaration of Helsinki, and all procedures were approved by the Yonsei University Health System Institutional Review Board (IRB No. 4-2014-0359) and the Institutional Review Board of the Samsung Medical Center (SMC 2015-09-880). All participants provided written informed consent prior to enrolment." To resolve this issue, the authors have verified the correct IRB approval details. The correct version of the Ethics approval and consent statement should be as below: This study was conducted in accordance with the principles outlined in the Declaration of Helsinki. All procedures were approved by the Yonsei University Health System Institutional Review Board (IRB No. 4-2014-0359) and the Institutional Review Board of the Samsung Medical Center (SMC 2014-09-056). Written informed consent was obtained from all participants. The authors apologize for the errors.